Toronto, ON (PRWEB) December 07, 2022 Stay on top of current hot topics through free webinars presented by leading experts in the pharma, biotech, medical
Toronto, ON (PRWEB) November 18, 2022 With the recent improvements of molecular blood culture identification (BCID) panels, time to pathogen and resistance
A weight loss of 5.5kg measured at 16 weeks of treatment in people with type 1 diabetes and a body mass index greater than 30kg/m2Glycemic control efficacy comparable to that obtained with the commercial reference insulin Humalog® (Eli Lilly)These results were presented at the 58th European Association for the Study.
Cancers often bypass antitumor immunity by affecting immune checkpoint expression, as such, immune checkpoint inhibition therapy is emerging as an attractive treatment in the battle against cancer.